The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
The Sensationalization of Medical Errors: Breaking Down the Data In Order to Improve Patient Care
May 23rd 2016Using data from four previously published studies and using mathematical models to extrapolate data to the current year, researchers at Johns Hopkins contended that medical errors were now the third leading cause of death in the US today.
Stroke Prevention: Meeting Challenges in Nigeria
Stroke prevention works, but it can be challenging in places like Nigeria where resources are limited, healthyfood is expensive, and cultural beliefs may include witchcraft. A San Diego, CA team is working on strategy for stroke patients.
Tips for Talking to a Dying Patient
May 11th 2016When a patient is dying, it can be difficult to know what to say to them. Here are a few tips and approaches that I have gathered from experts that I hope will help you get through those hard conversations while continuing to provide the best possible care to your patient.
SSRI Use Increases Risk of Post-Stroke Mortality in Patients with Diabetes
An analysis of population-based medical databases has found that strokes are more likely to prove fatal in diabetic patients who use selective serotonin reuptake inhibitors (SSRIs) than in diabetic patients who do not.